Oral infections such as periodontitis, peri implantitis, or wound healing complications after tooth extractions remain major challenges in dentistry. Commonly used antibiotics or systemic therapies often reach their limits: drug concentrations at the infection site are frequently insufficient, while side effects and resistance development pose additional risks. For this reason, locally active, bioactive materials are gaining increasing attention in research.

The treatment of complex bone defects, particularly in the cranio-maxillofacial region, remains a major clinical challenge. Autologous grafts are considered the gold standard, but they are associated with limitations such as resorption, insufficient fit, and infection risks.